Literature DB >> 34852636

Decellularized bovine aorta as a promising 3D elastin scaffold for vascular tissue engineering applications.

Tahmineh Kazemi1, Ahmad A Mohammadpour1, Maryam M Matin2, Nasser Mahdavi-Shahri3, Hesam Dehghani4, Seyed H Kazemi Riabi5.   

Abstract

Aim: To evaluate the suitability of using aorta elastin scaffold, in combination with human adipose-derived mesenchymal stem cells (hAd-MSCs), as an approach for cardiovascular tissue engineering. Materials &
Methods: Human adipose-derived MSCs were seeded on elastin samples of decellularized bovine aorta. The samples were cultured in vitro to investigate the inductive effects of this scaffold on the cells. The results were evaluated using histological, and immunohistochemical methods, as well as MTT assay, DNA content, reverse transcription-PCR and scanning electron microscopy.
Results: Histological staining and DNA content confirmed the efficacy of decellularization procedure (82% DNA removal). MTT assay showed the construct's ability to support cell viability and proliferation. Cell differentiation was confirmed by reverse transcription-PCR and positive immunohistochemistry for alfa smooth muscle actin and von Willebrand.
Conclusion: The prepared aortic elastin samples act as a potential scaffold, in combination with MSCs, for applications in cardiovascular tissue engineering. Further experiments in animal models are required to confirm this.

Entities:  

Keywords:  aorta regeneration; cardiovascular tissue engineering; elastin scaffold; extracellular matrix; mesenchymal stem cells; regenerative medicine

Mesh:

Substances:

Year:  2021        PMID: 34852636     DOI: 10.2217/rme-2021-0062

Source DB:  PubMed          Journal:  Regen Med        ISSN: 1746-0751            Impact factor:   3.806


  2 in total

1.  Assessing the biocompatibility of bovine tendon scaffold, a step forward in tendon tissue engineering.

Authors:  Elahe Khakpour; Amin Tavassoli; Nasser Mahdavi-Shahri; Maryam M Matin
Journal:  Cell Tissue Bank       Date:  2022-05-21       Impact factor: 1.522

Review 2.  Enhancing Stem Cell-Based Therapeutic Potential by Combining Various Bioengineering Technologies.

Authors:  In-Sun Hong
Journal:  Front Cell Dev Biol       Date:  2022-07-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.